Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Accumulated Expenses (2020 - 2025)

Beauty Health (SKIN) has disclosed Accumulated Expenses for 6 consecutive years, with $18.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses changed N/A to $18.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $18.8 million, a N/A change, with the full-year FY2024 number at $20.0 million, changed N/A from a year prior.
  • Accumulated Expenses was $18.8 million for Q3 2025 at Beauty Health, up from $15.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $20.0 million in Q4 2024 to a low of $801521.0 in Q1 2021.
  • A 5-year average of $14.9 million and a median of $15.4 million in 2022 define the central range for Accumulated Expenses.
  • Biggest YoY gain for Accumulated Expenses was 1449.43% in 2022; the steepest drop was 16.05% in 2022.
  • Beauty Health's Accumulated Expenses stood at $14.7 million in 2021, then rose by 4.5% to $15.4 million in 2022, then rose by 21.69% to $18.7 million in 2023, then grew by 6.84% to $20.0 million in 2024, then dropped by 6.21% to $18.8 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Accumulated Expenses are $18.8 million (Q3 2025), $15.0 million (Q2 2025), and $20.0 million (Q4 2024).